GeneDx Holdings Corp. Cash and Restricted Cash
GeneDx Holdings Corp. (WGS) had Cash and Restricted Cash of $61.31 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-03
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $61.31M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $94.92M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $105.99M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $96.96M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $61.31M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $94.92M 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $105.99M 10-Q · filed 2026-08-03 | |
| 2025-09-30 | $96.96M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $75.11M 10-Q · filed 2026-08-03 | |
| 2025-03-31 | $100.69M 10-Q · filed 2026-05-04 | |
| 2024-12-31 | $86.20M 10-Q · filed 2026-08-03 | |
| 2024-09-30 | $58.88M 10-Q · filed 2025-10-28 | |
| 2024-06-30 | $57.06M 10-Q · filed 2025-07-29 | |
| 2024-03-31 | $84.66M 10-Q · filed 2025-04-30 | |
| 2023-12-31 | $100.67M 10-K · filed 2026-02-23 | |
| 2023-09-30 | $88.29M 10-Q · filed 2024-10-29 | |
| 2023-06-30 | $157.56M 10-Q · filed 2024-07-30 | |
| 2023-03-31 | $214.94M 10-Q · filed 2024-04-29 | |
| 2022-12-31 | $138.30M 10-K · filed 2026-02-23 | |
| 2022-09-30 | $205.73M 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $299.02M 10-Q · filed 2023-08-08 | |
| 2022-03-31 | $315.90M 10-Q · filed 2023-05-09 | |
| 2021-12-31 | $401.47M 10-K · filed 2024-02-23 | |
| 2021-09-30 | $462.18M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $37.33M 10-Q · filed 2022-08-15 | $462.18M 10-Q · filed 2021-11-15 |
| 2021-03-31 | $69.48M 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $118.96M 10-K · filed 2023-03-16 | |
| 2020-09-30 | $139.68M 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $115.01M 10-K · filed 2023-03-16 | |
| 2018-12-31 | $1.18M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |